Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

University of Pittsburgh

Status: Enrolling

Conditions: Atopic Dermatitis; Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Eczema

Treatments: Other: Blood draw, skin biopsy or urine collection

Study type: Observational

Funder types: Other

Identifiers

NCT00177268

STUDY19010322

Details and patient eligibility

About

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Full description

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor:

• immunologic assays/flow cytometry
• tumor progression/regression
• genomic studies
• proteomic studies
• others germane to the advancement of CTCL treatment

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 or older
• able and willing to provide informed consent
• diagnosed with CTCL
• diagnosed with either atopic dermatitis or eczema

Exclusion criteria

• Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Trial design

200 participants in 1 patient group

CTCL, atopic dermatitis, eczema

Description:

Those subjects with cutaneous t-cell lymphoma and Sezary syndrome, atopic dermatitis, or eczema may participate as appropriate with the potential for blood, tissue or urine sampling.

Treatment:

Other: Blood draw, skin biopsy or urine collection